Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas - Wikidata - wikimedia - TriplyDB

Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas

Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas

http://www.wikidata.org/entity/Q33235035

about

Regulation of ERBB3/HER3 signaling in cancer Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma.Where now for anti-EGF receptor therapies in colorectal cancer?Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics.Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab.HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer.HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis HER3 over-expression and overall survival in gastrointestinal cancers System properties of ErbB receptor signaling for the understanding of cancer progression.ErbB3 is required for ductal morphogenesis in the mouse mammary gland.The ERBB3 receptor in cancer and cancer gene therapy ERBBs in the gastrointestinal tract: recent progress and new perspectives.Prognostic value of epidermal growth factor receptors in gastric cancer: a survival analysis by Weibull model incorporating long-term survivors.HER-3 expression in HER-2-amplified breast carcinoma.Potential of ErbB4 antibodies for cancer therapy.Colorectal cancer in review: the role of the EGFR pathway.Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors.The promise of anti-ErbB3 monoclonals as new cancer therapeutics Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers.HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy.HER3 expression is correlated to distally located and low-grade colon cancer.Advances in Targeting HER3 as an Anticancer Therapy Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers.HER3 protein expression in relation to HER2 positivity in patients with primary colorectal cancer: clinical relevance and prognostic value.HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma.Involvement of erbB4 and tumor marker genes in renal carcinoma regulatory network.Association between the overexpression of Her3 and clinical pathology and prognosis of colorectal cancer: A meta-analysis

P2860

Q27024334-1D36CCE8-4200-4F6C-BC69-D9B7FD730CC0 Q30430971-51082568-36AC-42E1-85BB-3899067E60BB Q31038305-76AFF28D-9F15-4958-8F2F-3F08501C8029 Q33846990-9179D723-7E68-4BA0-A071-868925312204 Q34082534-2B83FE1F-5C97-492A-A6DB-1AB095659485 Q34349389-17C7337B-A603-4334-92EC-83F6BB116DA7 Q34586892-2B930BCD-7B72-4D0D-BC87-182AEC8929E9 Q35584314-F7EB44C0-80EC-4E7B-B043-A7CD08C2FF2E Q36020920-387EBE50-E3EB-4143-ACDE-6DC701D0B926 Q36106546-C4BBBC20-B2A4-46AC-87C4-2BB8903D0B2C Q36619051-0CE2C43D-9924-4AF1-AC6A-98C3B893D412 Q36716462-4D9015D4-E228-48C7-B19D-6545932DABFE Q37131318-719BF525-0718-4EA9-83C3-7306D8DF34D3 Q37135372-61D25C72-9E54-44B9-8A68-19EF4BF7E99B Q37337542-539DD8A9-7C9C-48CB-BBC5-F9D5CEAFA739 Q37468304-43793BC7-5B04-4F24-91E0-CD3BE0C994E0 Q37601863-12DFFA81-F9D0-429A-BE01-D44CE49475A4 Q37658764-945C1BCA-32EB-4E89-8C99-FBA45B62CF4C Q37679938-5C9A9DD2-E692-4151-8DB2-730D44089691 Q37974158-337A471B-50C0-4BC8-80C1-AAB09D4E7B49 Q38034347-A1888EAC-1C66-432E-87F6-8A166C993808 Q38073827-23F2E852-82B7-474F-8334-8AB790899F18 Q39368710-094E8B24-BD2A-4700-82CB-3DF055B220FE Q40918277-0EC8F2E1-77EC-445E-ADE1-6CE0E2DE5793 Q41621146-2D124749-D6C1-4DE7-B3C3-30CDB8523CF8 Q47396247-E47A1975-A2DC-436C-B54C-6EBFF5B49778 Q54286661-CB9E2EE0-B7C9-4DF8-AD65-26CD5D6C18D6 Q54478596-0497980D-77F2-4834-903C-5A189649E757 Q55000715-24D9BC82-9861-4D93-ADE2-E5AB7D166BCC Q58739568-A26CC6AC-D27B-4DB5-A172-2F30A7C4904C

P2860

Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas

http://www.wikidata.org/entity/Q33235035

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas

@ast

Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas

@en

type

label

Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas

@ast

Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas

@en

prefLabel

Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas

@ast

Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas

@en

P1433

Q33235035-98DAC728-27C0-419E-B3A6-8F0CFA41E4BA

P1476

Q33235035-398B5171-FB08-449F-8F16-75B594ED5697

P2093

Q33235035-1596B782-E804-4AFF-96C4-31941D2BEE65

Q33235035-165FF6A9-D266-4F63-BA69-D427E60CAF45

Q33235035-31B4EB91-644A-4105-8AE1-DB133D5EFCFE

Q33235035-3526B3DF-E098-4E78-87E0-FA7C636299EB

Q33235035-56217827-11E3-43E8-AB37-CC26C36B4588

Q33235035-8FFBF479-1E4D-4CC3-AD52-E3282C759C05

Q33235035-BFE06D5B-B2F4-4C64-862A-77B37D117FBF

Q33235035-F41189B3-693E-4493-8C37-34087413D9AD

P2860

Q33235035-009A9822-8138-4D95-9BED-7A654BF6D883

Q33235035-09CF932A-BF10-43CA-8C61-6C763D71B178

Q33235035-09D8EFB1-CC01-4A29-B746-98A4B07A8AC8

Q33235035-0A58F812-F1A6-4A05-BDC3-7A13B142B031

Q33235035-16D10857-EC7B-41A1-BF3E-BEE4B3994F9D

Q33235035-1A9D498D-0CEE-4539-A5B0-713423E1DC2C

Q33235035-38C2F226-4F4C-4300-A92C-21A06CFBEE1A

Q33235035-54B6F6AE-1B5A-42F7-97B9-11F62D91746B

Q33235035-649C6FD2-7E19-4CF4-9D91-C6E04B0DFB12

Q33235035-6A1F8889-B26A-4C5C-8E81-4B96A7C5B41C

P2888

Q33235035-E0EEF282-835C-4A31-BCFF-B1BCA9B7A025

P304

Q33235035-067671C7-0BE5-44AA-AD1C-42BC05135F2F

P31

Q33235035-0611CFA9-A4EC-46D4-BAB9-85212C2477A4

P356

Q33235035-B803456D-01E8-4950-BF49-5EEF1DBF0A83

P407

Q33235035-E84BE54E-8031-4A24-AB76-FEE323B2D6F5

P478

Q33235035-CE9F570A-AE19-4561-B5CD-67372F0A9500

P577

Q33235035-1A565D86-F192-4F7B-9CD7-890C5AF604E0

P5875

Q33235035-FA319379-E546-47D3-9C83-F44CF80E257A

P6179

Q33235035-A5D917CA-7557-467B-B085-5566829A9353

P698

Q33235035-0397D3FB-AC93-457D-9905-06D31DE7190E

P921

Q33235035-B470FA0A-3DFA-490C-B3B0-8B034A6D6B73

P932

Q33235035-8BD0A52B-4D9F-41AC-BECE-CBE5D6214AD9

P356

P1433

P1476

Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas

@en

P2093

Amanda Psyrri

http://www.w3.org/2001/XMLSchema#string

Dimitra Rontogianni

http://www.w3.org/2001/XMLSchema#string

Dimitrios Pectasides

http://www.w3.org/2001/XMLSchema#string

Efstratios Patsouris

http://www.w3.org/2001/XMLSchema#string

Kitty Pavlakis

http://www.w3.org/2001/XMLSchema#string

Nikolaos Xiros

http://www.w3.org/2001/XMLSchema#string

Panteleimon Kountourakis

http://www.w3.org/2001/XMLSchema#string

Theofanis Economopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Epidermal growth factor-related peptides and their receptors in human malignancies

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

The ErbB signaling network: receptor heterodimerization in development and cancer

Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms

HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer.

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.

The subcellular localization of the neu protein in human normal and neoplastic cells.

The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study.

P2888

P304

46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-6-46

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2006-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7270870

http://www.w3.org/2001/XMLSchema#string

P6179

1042033156

http://www.w3.org/2001/XMLSchema#string

P698

16507107

http://www.w3.org/2001/XMLSchema#string

P921

P932

1431553

http://www.w3.org/2001/XMLSchema#string